Global Coronavirus Diagnostics Market By Type of Test (Molecular v/s Serology), By User (Multiple v/s Single), By Full Test Time (1 Hour - 12 Hours, Less Than 60 Minutes, 13 Hours - 24 Hours, More Than 1 Day), By End User (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs, Others), By Region, Competition Forecast & Opportunities, 2026

Global coronavirus diagnostics market was valued at USD73538.02 million in 2020 and is expected to reach USD15579.56 million by 2026.The global coronavirus diagnostics market is driven by surging incidences of this disease across different parts of the globe. The market is segmented based on type of test, user, full test time, end user, company and region. Based on type of test, market can be bifurcated into molecular and serological tests. The molecular type of test segment is expected to dominate the market during forecast period. In this testing procedure, a sample from the back of the throat is taken and sent for testing. The sample undergoes a PCR test to find out the presence of virus genetic material. The PCR confirms the diagnosis of COVID-19 if it finds two genes of SARS-COV-2 virus.

The ongoing coronavirus disease is caused due to SARS-COV-2 virus and generally spreads from animals to humans and then from humans to humans. The disease usually spreads from saliva droplets of the infected person or the nose discharges of the infected person when they cough or sneeze. First case of the disease was reported in December 2019 in Wuhan, China and since then, it has spread to various parts of the world infecting millions. As of 20^th May 2021, the total number of coronavirus cases crossed 165 million, globally, of which around 144 million had recovered and over 3 million people had died.

Europe and Asia-Pacific are expected to dominate the market during the forecast period owing to the presence of many research laboratories and pharmaceutical & biotechnology companies across the regions. Major players operating in the coronavirus diagnostics market include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Danaher Corporation, Siemens AG, Thermo Fisher Scientific Inc., Mylab Discovery Solutions Pvt. Ltd., Bio-Rad Laboratories, Inc., BioMerieux SA, GSK Biologicals SA, Altona Diagnostics GmbH, Seegene Inc., PerkinElmer, Inc., Quest Diagnostics Inc., Hologic, Inc., Quidel Corporation, and others.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022–2026

Objective of the Study:

To analyze the historical growth in the market size of the global coronavirus diagnostics market from 2016 to 2020.
To estimate and forecast the market size of the global coronavirus diagnostics market from 2021 to 2026 and growth rate until 2026.
To classify and forecast global coronavirus diagnostics market based on type of test, user, full test time, end user, company and regional distribution.
To identify dominant regions and segments in the global coronavirus diagnostics market.
To identify drivers and challenges for global coronavirus diagnostics market.
To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global coronavirus diagnostics market.
To identify and analyze the profile of leading players operating in global coronavirus diagnostics market.
To identify key sustainable strategies adopted by market players in global coronavirus diagnostics market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of diagnostic players operating across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the market players which could not be identified due to the limitations of secondary research.

TechSci Research calculated the market size of global coronavirus diagnostics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

Coronavirus diagnostic kits manufacturers, suppliers, distributors and other stakeholders
Government bodies such as regulating authorities and policy makers
Organizations, forums and alliances related to coronavirus diagnostics
Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders, besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global coronavirus diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Coronavirus Diagnostics Market, By Type of Test:

Molecular
Serology

Global Coronavirus Diagnostics Market, By User:

Multiple
Single

Global Coronavirus Diagnostics Market, By Full Test Time:

1 Hour - 12 Hours
Less Than 60 Minutes
13 Hours - 24 Hours
More Than 1 Day

Global Coronavirus Diagnostics Market, By End User:

Hospitals
Public Health Labs
Private or Commercial Labs
Physician Labs
Others

Global Coronavirus Diagnostics Market, By Region:

Europe

United Kingdom
Russia
France
Italy
Germany
Spain

Asia-Pacific

India
China
Australia
Japan
Singapore
South Korea
Thailand

North America

United States
Canada
Mexico

Middle East & Africa

UAE
Saudi Arabia
Iran
South Africa
Kuwait

South America

Brazil
Colombia
Argentina

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global coronavirus diagnostics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Coronavirus Diagnostics Market

5. Voice of Customer

5.1. Brand Awareness (Aided/Unaided)

5.2. Product Awareness

5.3. Customer Satisfaction Analysis

5.4. Pricing Analysis

5.5. Unmet Needs/Challenges

6. Global Coronavirus Diagnostics Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value & Volume

6.2. Market Share & Forecast

6.2.1. By Type of Test (Molecular v/s Serology)

6.2.2. By User (Multiple v/s Single)

6.2.3. By Full Test Time (1 Hours to 12 Hours, Less Than 60 Minutes, 13 Hours-24 Hours, More Than 1 Days)

6.2.4. By End User (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs, Others)

6.2.5. By Company (2020)

6.2.6. By Region

6.3. Product Market Map

7. Europe Coronavirus Diagnostics Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value & Volume

7.2. Market Share & Forecast

7.2.1. By Type of Test

7.2.2. By User

7.2.3. By Full Test Time

7.2.4. By End User

7.2.5. By Country

7.3. Europe: Country Analysis

7.3.1. United Kingdom Coronavirus Diagnostics Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value & Volume

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Type of Test

7.3.1.2.2. By User

7.3.1.2.3. By Full Test Time

7.3.1.2.4. By End User

7.3.2. Russia Coronavirus Diagnostics Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value & Volume

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Type of Test

7.3.2.2.2. By User

7.3.2.2.3. By Full Test Time

7.3.2.2.4. By End User

7.3.3. France Coronavirus Diagnostics Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value & Volume

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Type of Test

7.3.3.2.2. By User

7.3.3.2.3. By Full Test Time

7.3.3.2.4. By End User

7.3.4. Italy Coronavirus Diagnostics Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value & Volume

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Type of Test

7.3.4.2.2. By User

7.3.4.2.3. By Full Test Time

7.3.4.2.4. By End User

7.3.5. Germany Coronavirus Diagnostics Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value & Volume

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Type of Test

7.3.5.2.2. By User

7.3.5.2.3. By Full Test Time

7.3.5.2.4. By End User

7.3.6. Spain Coronavirus Diagnostics Market Outlook

7.3.6.1. Market Size & Forecast

7.3.6.1.1. By Value & Volume

7.3.6.2. Market Share & Forecast

7.3.6.2.1. By Type of Test

7.3.6.2.2. By User

7.3.6.2.3. By Full Test Time

7.3.6.2.4. By End User

8. Asia-Pacific Coronavirus Diagnostics Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value & Volume

8.2. Market Share & Forecast

8.2.1. By Type of Test

8.2.2. By User

8.2.3. By End User

8.2.4. By Full Test Time

8.2.5. By Country

8.3. Asia-Pacific: Country Analysis

8.3.1. India Coronavirus Diagnostics Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value & Volume

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Type of Test

8.3.1.2.2. By User

8.3.1.2.3. By Full Test Time

8.3.1.2.4. By End User

8.3.2. China Coronavirus Diagnostics Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value & Volume

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Type of Test

8.3.2.2.2. By User

8.3.2.2.3. By Full Test Time

8.3.2.2.4. By End User

8.3.3. Australia Coronavirus Diagnostics Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value & Volume

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Type of Test

8.3.3.2.2. By User

8.3.3.2.3. By Full Test Time

8.3.3.2.4. By End User

8.3.4. Japan Coronavirus Diagnostics Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value & Volume

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Type of Test

8.3.4.2.2. By User

8.3.4.2.3. By Full Test Time

8.3.4.2.4. By End User

8.3.5. Singapore Coronavirus Diagnostics Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value & Volume

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Type of Test

8.3.5.2.2. By User

8.3.5.2.3. By Full Test Time

8.3.5.2.4. By End User

8.3.6. South Korea Coronavirus Diagnostics Market Outlook

8.3.6.1. Market Size & Forecast

8.3.6.1.1. By Value & Volume

8.3.6.2. Market Share & Forecast

8.3.6.2.1. By Type of Test

8.3.6.2.2. By User

8.3.6.2.3. By Full Test Time

8.3.6.2.4. By End User

8.3.7. Thailand Coronavirus Diagnostics Market Outlook

8.3.7.1. Market Size & Forecast

8.3.7.1.1. By Value & Volume

8.3.7.2. Market Share & Forecast

8.3.7.2.1. By Type of Test

8.3.7.2.2. By User

8.3.7.2.3. By Full Test Time

8.3.7.2.4. By End User

9. North America Coronavirus Diagnostics Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value & Volume

9.2. Market Share & Forecast

9.2.1. By Type of Test

9.2.2. By User

9.2.3. By Full Test Time

9.2.4. By End User

9.2.5. By Country

9.3. North America: Country Analysis

9.3.1. United States Coronavirus Diagnostics Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value & Volume

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Type of Test

9.3.1.2.2. By User

9.3.1.2.3. By Full Test Time

9.3.1.2.4. By End User

9.3.2. Canada Coronavirus Diagnostics Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value & Volume

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Type of Test

9.3.2.2.2. By User

9.3.2.2.3. By Full Test Time

9.3.2.2.4. By End User

9.3.3. Mexico Coronavirus Diagnostics Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value & Volume

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Type of Test

9.3.3.2.2. By User

9.3.3.2.3. By Full Test Time

9.3.3.2.4. By End User

10. Middle East & Africa Coronavirus Diagnostics Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value & Volume

10.2. Market Share & Forecast

10.2.1. By Type of Test

10.2.2. By User

10.2.3. By Full Test Time

10.2.4. By End User

10.2.5. By Country

10.3. Middle East & Africa: Country Analysis

10.3.1. UAE Coronavirus Diagnostics Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value & Volume

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Type of Test

10.3.1.2.2. By User

10.3.1.2.3. By Full Test Time

10.3.1.2.4. By End User

10.3.2. Saudi Arabia Coronavirus Diagnostics Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value & Volume

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Type of Test

10.3.2.2.2. By User

10.3.2.2.3. By Full Test Time

10.3.2.2.4. By End User

10.3.3. Iran Coronavirus Diagnostics Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value & Volume

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Type of Test

10.3.3.2.2. By User

10.3.3.2.3. By Full Test Time

10.3.3.2.4. By End User

10.3.4. South Africa Coronavirus Diagnostics Market Outlook

10.3.4.1. Market Size & Forecast

10.3.4.1.1. By Value & Volume

10.3.4.2. Market Share & Forecast

10.3.4.2.1. By Type of Test

10.3.4.2.2. By User

10.3.4.2.3. By Full Test Time

10.3.4.2.4. By End User

10.3.5. Kuwait Coronavirus Diagnostics Market Outlook

10.3.5.1. Market Size & Forecast

10.3.5.1.1. By Value & Volume

10.3.5.2. Market Share & Forecast

10.3.5.2.1. By Type of Test

10.3.5.2.2. By User

10.3.5.2.3. By Full Test Time

10.3.5.2.4. By End User

11. South America Coronavirus Diagnostics Market Outlook

11.1. Market Size & Forecast

11.1.1. By Value & Volume

11.2. Market Share & Forecast

11.2.1. By Type of Test

11.2.2. By User

11.2.3. By Full Test Time

11.2.4. By End User

11.2.5. By Country

11.3. South America: Country Analysis

11.3.1. Brazil Coronavirus Diagnostics Market Outlook

11.3.1.1. Market Size & Forecast

11.3.1.1.1. By Value & Volume

11.3.1.2. Market Share & Forecast

11.3.1.2.1. By Type of Test

11.3.1.2.2. By User

11.3.1.2.3. By Full Test Time

11.3.1.2.4. By End User

11.3.2. Colombia Coronavirus Diagnostics Market Outlook

11.3.2.1. Market Size & Forecast

11.3.2.1.1. By Value & Volume

11.3.2.2. Market Share & Forecast

11.3.2.2.1. By Type of Test

11.3.2.2.2. By User

11.3.2.2.3. By Full Test Time

11.3.2.2.4. By End User

11.3.3. Argentina Coronavirus Diagnostics Market Outlook

11.3.3.1. Market Size & Forecast

11.3.3.1.1. By Value & Volume

11.3.3.2. Market Share & Forecast

11.3.3.2.1. By Type of Test

11.3.3.2.2. By User

11.3.3.2.3. By Full Test Time

11.3.3.2.4. By End User

12. Market Dynamics

12.1. Drivers

12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

14.1. Abbott Laboratories

14.2. Altona Diagnostics GmbH

14.3. BioMerieux SA

14.4. Bio-Rad Laboratories, Inc.

14.5. Danaher Corporation

14.6. F.Hoffmann-La Roche Ltd

14.7. GSK Biologicals SA

14.8. Mylab Discovery Solutions Pvt. Ltd.

14.9. Seegene Inc.

14.10. Siemens AG

14.11. Thermo Fisher Scientific Inc.

14.12. PerkinElmer, Inc.

14.13. Quest Diagnostics Inc.

14.14. Hologic, Inc.

14.15. Quidel Corporation

15. Strategic Recommendations

16. About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]

List of Figures

Figure 1: Global Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 2: Global Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 3: Global Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 4: Global Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 5: Global Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 6: Global Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 7: Global Coronavirus Diagnostics Market, Product Market Map, By Company, By Value (USD Million), 2016-2026F

Figure 8: Global Coronavirus Diagnostics Market, Product Market Map, By Region, By Value (USD Million), 2016-2026F

Figure 9: Europe Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 10: Europe Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 11: Europe Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 12: Europe Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 13: Europe Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 14: Europe Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 15: Europe Coronavirus Diagnostics Market, By Country, 2016-2026F

Figure 16: United Kingdom Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 17: United Kingdom Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 18: United Kingdom Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 19: United Kingdom Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 20: United Kingdom Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 21: United Kingdom Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 22: Russia Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 23: Russia Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 24: Russia Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 25: Russia Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 26: Russia Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 27: Russia Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 28: France Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 29: France Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 30: France Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 31: France Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 32: France Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 33: France Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 34: Italy Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 35: Italy Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 36: Italy Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 37: Italy Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 38: Italy Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 39: Italy Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 40: Germany Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 41: Germany Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 42: Germany Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 43: Germany Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 44: Germany Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 45: Germany Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 46: Spain Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 47: Spain Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 48: Spain Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 49: Spain Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 50: Spain Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 51: Spain Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 52: Asia-Pacific Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 53: Asia-Pacific Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 54: Asia-Pacific Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 55: Asia-Pacific Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 56: Asia-Pacific Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 57: Asia-Pacific Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 58: Asia-Pacific Coronavirus Diagnostics Market, By Country, 2016-2026F

Figure 59: India Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 60: India Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 61: India Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 62: India Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 63: India Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 64: India Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 65: China Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 66: China Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 67: China Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 68: China Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 69: China Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 70: China Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 71: Australia Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 72: Australia Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 73: Australia Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 74: Australia Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 75: Australia Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 76: Australia Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 77: Japan Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 78: Japan Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 79: Japan Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 80: Japan Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 81: Japan Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 82: Japan Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 83: Singapore Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 84: Singapore Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 85: Singapore Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 86: Singapore Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 87: Singapore Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 88: Singapore Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 89: South Korea Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 90: South Korea Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 91: South Korea Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 92: South Korea Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 93: South Korea Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 94: South Korea Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 95: Thailand Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 96: Thailand Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 97: Thailand Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 98: Thailand Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 99: Thailand Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 100: Thailand Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 101: North America Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 102: North America Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 103: North America Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 104: North America Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 105: North America Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 106: North America Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 107: North America Coronavirus Diagnostics Market, By Country, 2016-2026F

Figure 108: United States Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 109: United States Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 110: United States Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 111: United States Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 112: United States Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 113: United States Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 114: Canada Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 115: Canada Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 116: Canada Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 117: Canada Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 118: Canada Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 119: Canada Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 120: Mexico Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 121: Mexico Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 122: Mexico Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 123: Mexico Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 124: Mexico Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 125: Mexico Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 126: Middle East & Africa Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 127: Middle East & Africa Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 128: Middle East & Africa Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 129: Middle East & Africa Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 130: Middle East & Africa Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 131: Middle East & Africa Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 132: Middle East & Africa Coronavirus Diagnostics Market, By Country, 2016-2026F

Figure 133: UAE Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 134: UAE Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 135: UAE Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 136: UAE Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 137: UAE Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 138: UAE Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 139: Saudi Arabia Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 140: Saudi Arabia Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 141: Saudi Arabia Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 142: Saudi Arabia Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 143: Saudi Arabia Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 144: Saudi Arabia Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 145: Iran Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 146: Iran Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 147: Iran Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 148: Iran Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 149: Iran Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 150: Iran Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 151: South Africa Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 152: South Africa Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 153: South Africa Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F

Figure 154: South Africa Coronavirus Diagnostics Market Share, By User, 2016-2026F

Figure 155: South Africa Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F

Figure 156: South Africa Coronavirus Diagnostics Market Share, By End User, 2016-2026F

Figure 157: Kuwait Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F

Figure 158: Kuwait Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F

Figure 159: Kuwait Coronavirus Diagnostics Market Share, By Type of Test, 20

Report Description